These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 9549132

  • 1. [Response to sertraline in adolescents with obsessive-compulsive disorder].
    Rodríguez-Ramos P, Mardomingo Sanz MJ.
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(1):17-21. PubMed ID: 9549132
    [Abstract] [Full Text] [Related]

  • 2. Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial.
    March JS, Biederman J, Wolkow R, Safferman A, Mardekian J, Cook EH, Cutler NR, Dominguez R, Ferguson J, Muller B, Riesenberg R, Rosenthal M, Sallee FR, Wagner KD, Steiner H.
    JAMA; 1998 Nov 25; 280(20):1752-6. PubMed ID: 9842950
    [Abstract] [Full Text] [Related]

  • 3. A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder.
    Greist JH, Jefferson JW, Kobak KA, Chouinard G, DuBoff E, Halaris A, Kim SW, Koran L, Liebowtiz MR, Lydiard B.
    Int Clin Psychopharmacol; 1995 Jun 25; 10(2):57-65. PubMed ID: 7673657
    [Abstract] [Full Text] [Related]

  • 4. Will pindolol augment the response to a serotonin reuptake inhibitor in obsessive-compulsive disorder?
    Koran LM, Mueller K, Maloney A.
    J Clin Psychopharmacol; 1996 Jun 25; 16(3):253-4. PubMed ID: 8784659
    [No Abstract] [Full Text] [Related]

  • 5. A 2-year study of sertraline in the treatment of obsessive-compulsive disorder.
    Rasmussen S, Hackett E, DuBoff E, Greist J, Halaris A, Koran LM, Liebowitz M, Lydiard RB, McElroy S, Mendels J, O'Connor K.
    Int Clin Psychopharmacol; 1997 Nov 25; 12(6):309-16. PubMed ID: 9547132
    [Abstract] [Full Text] [Related]

  • 6. Sertraline treatment of children and adolescents with obsessive-compulsive disorder or depression: pharmacokinetics, tolerability, and efficacy.
    Alderman J, Wolkow R, Chung M, Johnston HF.
    J Am Acad Child Adolesc Psychiatry; 1998 Apr 25; 37(4):386-94. PubMed ID: 9549959
    [Abstract] [Full Text] [Related]

  • 7. Pharmacologic management of obsessive-compulsive disorder.
    Jackson CW, Morton WA, Lydiard RB.
    South Med J; 1994 Mar 25; 87(3):310-21. PubMed ID: 8134850
    [Abstract] [Full Text] [Related]

  • 8. Sertraline in the treatment of obsessive compulsive disorder: two double-blind, placebo-controlled studies.
    Chouinard G.
    Int Clin Psychopharmacol; 1992 Oct 25; 7 Suppl 2():37-41. PubMed ID: 1484177
    [Abstract] [Full Text] [Related]

  • 9. Pharmacologic treatment of obsessive-compulsive disorder: comparative studies.
    Flament MF, Bisserbe JC.
    J Clin Psychiatry; 1997 Oct 25; 58 Suppl 12():18-22. PubMed ID: 9393392
    [Abstract] [Full Text] [Related]

  • 10. Sertraline and mental retardation with obsessive-compulsive disorder.
    Wiener K, Lamberti JS.
    Am J Psychiatry; 1993 Aug 25; 150(8):1270. PubMed ID: 8328577
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of risperidone-induced obsessive-compulsive symptoms with sertraline.
    Dodt JE, Byerly MJ, Cuadros C, Christensen RC.
    Am J Psychiatry; 1997 Apr 25; 154(4):582. PubMed ID: 9090357
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of clozapine-induced obsessive-compulsive symptoms with sertraline.
    Allen L, Tejera C.
    Am J Psychiatry; 1994 Jul 25; 151(7):1096-7. PubMed ID: 8010373
    [No Abstract] [Full Text] [Related]

  • 13. Sertraline in the treatment of neurotic excoriations and related disorders.
    Kalivas J, Kalivas L, Gilman D, Hayden CT.
    Arch Dermatol; 1996 May 25; 132(5):589-90. PubMed ID: 8624163
    [No Abstract] [Full Text] [Related]

  • 14. Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder.
    Greist J, Chouinard G, DuBoff E, Halaris A, Kim SW, Koran L, Liebowitz M, Lydiard RB, Rasmussen S, White K.
    Arch Gen Psychiatry; 1995 Apr 25; 52(4):289-95. PubMed ID: 7702445
    [Abstract] [Full Text] [Related]

  • 15. High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial.
    Ninan PT, Koran LM, Kiev A, Davidson JR, Rasmussen SA, Zajecka JM, Robinson DG, Crits-Christoph P, Mandel FS, Austin C.
    J Clin Psychiatry; 2006 Jan 25; 67(1):15-22. PubMed ID: 16426083
    [Abstract] [Full Text] [Related]

  • 16. Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder.
    Chouinard G, Goodman W, Greist J, Jenike M, Rasmussen S, White K, Hackett E, Gaffney M, Bick PA.
    Psychopharmacol Bull; 1990 Jan 25; 26(3):279-84. PubMed ID: 2274626
    [Abstract] [Full Text] [Related]

  • 17. Sertraline and fluoxetine treatment of obsessive-compulsive disorder: results of a double-blind, 6-month treatment study.
    Bergeron R, Ravindran AV, Chaput Y, Goldner E, Swinson R, van Ameringen MA, Austin C, Hadrava V.
    J Clin Psychopharmacol; 2002 Apr 25; 22(2):148-54. PubMed ID: 11910259
    [Abstract] [Full Text] [Related]

  • 18. Panic attacks precipitated by sertraline.
    Zinner SH.
    Am J Psychiatry; 1994 Jan 25; 151(1):147-8. PubMed ID: 8267115
    [No Abstract] [Full Text] [Related]

  • 19. [Torin (sertraline) in the treatment of depressive and obsessive-compulsive disorders in children].
    Malinina EV, Zabozlaeva IV.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010 Jan 25; 110(8):22-4. PubMed ID: 20823825
    [Abstract] [Full Text] [Related]

  • 20. Behavioral therapy in children and adolescents with obsessive-compulsive disorder: a pilot study.
    Scahill L, Vitulano LA, Brenner EM, Lynch KA, King RA.
    J Child Adolesc Psychopharmacol; 1996 Jan 25; 6(3):191-202. PubMed ID: 9231312
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.